GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tectonic Therapeutic Inc (NAS:TECX) » Definitions » Other Current Assets

TECX (Tectonic Therapeutic) Other Current Assets : $3.40 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Tectonic Therapeutic Other Current Assets?

Tectonic Therapeutic's other current assets for the quarter that ended in Mar. 2025 was $3.40 Mil.

Tectonic Therapeutic's quarterly other current assets increased from Sep. 2024 ($3.50 Mil) to Dec. 2024 ($5.62 Mil) but then declined from Dec. 2024 ($5.62 Mil) to Mar. 2025 ($3.40Mil).

Tectonic Therapeutic's annual other current assets increased from Dec. 2022 ($1.08 Mil) to Dec. 2023 ($2.12 Mil) increased from Dec. 2023 ($2.12 Mil) to Dec. 2024 ($5.62 Mil).


Tectonic Therapeutic Other Current Assets Historical Data

The historical data trend for Tectonic Therapeutic's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tectonic Therapeutic Other Current Assets Chart

Tectonic Therapeutic Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Other Current Assets
0.56 1.08 2.12 5.62

Tectonic Therapeutic Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.26 3.50 5.62 3.40

Tectonic Therapeutic Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.


Tectonic Therapeutic Other Current Assets Related Terms

Thank you for viewing the detailed overview of Tectonic Therapeutic's Other Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Tectonic Therapeutic Business Description

Traded in Other Exchanges
N/A
Address
490 Arsenal Way, Suite 210, Watertown, MA, USA, 02472
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.